SCHEMBL20142501

SCHEMBL20142501

CN(C)c1nc(Nc2ccc(C(F)(F)F)cc2)sc1C(=O)c1ccncc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 8/20 0.49
CDK5R1 Q15078 8/20 0.49
ADORA3 P0DMS8 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47
CCNA2 P20248 4/20 0.46
CDK2 P24941 4/20 0.46
DHODH Q02127 2/20 0.45
MAPT P10636 3/20 0.45
NPC1 O15118 5/20 0.44
RAB9A P51151 3/20 0.44
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
MAPK14 Q16539 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ADORA2B P29275 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20142391 0.90 EPHX2 (0.48) CDK5CDK5R1ADORA3ADORA2AADORA1
SCHEMBL20142497 0.89 CCNA2 (0.55) CDK5CDK5R1ADORA3ADORA2AADORA1
SCHEMBL20142267 0.87 GSK3A (0.51) CDK5CDK5R1ADORA3ADORA2AADORA1
SCHEMBL20142465 0.87 CDK5 (0.52) CDK5CDK5R1ADORA3ADORA2AADORA1
SCHEMBL20141898 0.83 CDK5 (0.71) CDK5CDK5R1CCNA2CDK2MAPT
SCHEMBL20142504 0.81 CCNA2 (0.49) CDK5CDK5R1ADORA3ADORA2AADORA1
SCHEMBL20142105 0.78 CDK5 (0.67) CDK5CDK5R1CCNA2CDK2MAPT
SCHEMBL20142841 0.77 MAPT (0.63) CDK5CDK5R1ADORA3ADORA2AADORA1
SCHEMBL20142452 0.77 NPC1 (0.50) CDK5CDK5R1ADORA3ADORA2AADORA1
SCHEMBL20142402 0.76 NPC1 (0.57) CDK5CDK5R1CCNA2CDK2DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089902-A1 DIAMINOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE APOGEE BIOTECHNOLOGY CORPORATION (US) 2018-05-17 WO disclosed